Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Stille AB (publ) today presents the report for the second quarter 2026.

STILRegulatory press release23.07.2026 klo 09.00
Download the release

Net sales amounted to MSEK 186.9 (124.7), which corresponds to an organic growth of 26.7% (27.9% in constant currencies) and a total growth of 49.9% (50.9% in constant currencies).

”The first half of 2026 has been very encouraging with significant growth both in revenue and profitability across the business, says Ulrik Berthelsen. Product availability continues to improve, helping to further drive demand for our products. In parallel, we continue to evaluate opportunities for additional acquisitions and we are strengthening our team to further accelerate M&A activities.”

The gross margin was 48.4% (52.1) and EBITDA before non-recurring items amounted to MSEK 36.5 (24.4).

”We look forward to the second half of 2026 and further evolving the Stille Group”, the Stille CEO concludes.

MSEKAPR-JUN
2026
APR-JUN
2025
JAN-JUN
2026
JAN-JUN
2025
JUL-JUN
2025/2026
JAN-DEC
2025
Net sales186.9124.7365.9254.0679.6567.6
Gross profit. %48.452.148.851.647.150.7
EBITDA before non-recurring items36.524.475.049.6139.2113.8
EBITDA before non-recurring items. %19.619.620.519.520.520.0
EBITDA36.524.475.049.6132.1106.7
EBITDA. %19.619.620.519.519.418.8
EBIT before non-recurring items27.416.657.434.5103.280.3
EBIT before non-recurring items. %14.613.315.713.615.214.2
EBIT27.416.657.434.596.173.2
EBIT. %14.613.315.713.615.012.9

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-07-23 08:00 CEST.

Contact Details
Ulrik Berthelsen
CEO & President
+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se

About Us
Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se.

Attachments
Interim Report Stille Q2 2026